CARB-X

CARB-X

CARB-X

Suggest edits
Follow us
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 6

Portfolio

Portfolio Tracker

Add info
Pulse 2.0

Cidara Therapeutics Stock Price Increased Over 5% Pre-Market: Why It Happened

Cidara Therapeutics
Cidara Therapeutics
FinSMEs

Vedanta Biosciences Raises $16.6M in Series C-2 Financing

Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc.
$75,000,000 IPO
PE HUB

VC-backed Entasis Therapeutics debuts IPO

Entasis Therapeutics
Entasis Therapeutics
$9,400,000 Grant
businesswire

VenatoRx Pharmaceuticals Receives $9.4 Million Award from CARB-X to Develop a New Class of Antibiotic to Combat Multi-Dr...

VenatoRx Pharmaceuticals Inc.
VenatoRx Pharmaceuticals Inc.
CARB-X
CARB-X
$6,300,000 Grant
GEN

Entasis Wins Up to $6.3M from CARB-X for MDR Antibacterial Drug Development Genetic Engineering & Biotechnology News - B...

Entasis Therapeutics
Entasis Therapeutics
CARB-X
CARB-X
MDR
MDR
$6,900,000 Grant
biospace , businesswire

Cidara Awarded 6 9 Million Grant From CARB X To Advance Development Of Its First Cloudbreak Antibiotic Immunotherapy

Cidara Therapeutics
Cidara Therapeutics
Xconomy

Forge Therapeutics Raises $15M to Take on Drug-Resistant Superbugs

Health Science Funding
Forge Therapeutics
Forge Therapeutics
PE HUB

Forge Therapeutics snaps up $15 mln Series A

Funding Data leaks
Forge Therapeutics
Forge Therapeutics
$1,000,000 Grant
North West

Redx gets $1m boost from global public private alliance

RedxPharmaPlc
RedxPharmaPlc
$8,800,000 Grant
prnewswire

Forge Therapeutics Wins Powered by CARB-X Research Award of $8.8M to Accelerate Development of its LpxC Antibiotic to Ki...

Forge Therapeutics
Forge Therapeutics
$20,000,000 Post-IPO debt
FinSMEs

Cidara Therapeutics Receives $20M Credit Facility from Square 1 Bank